US2003036636A1PendingUtilityA1
Process for preparing porous collagen matrix from connective tissue
Est. expiryAug 17, 2021(expired)· nominal 20-yr term from priority
A61L 27/3604A61L 27/24A61L 27/3687A61L 27/56C08H 1/06C08L 89/06
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The subject invention provides a process for preparing a porous collagen matrix from connective tissue, which comprises treating connective tissue with a solution of hydrogen peroxide and/or an acidic solution so as to obtain a porous collagen matrix.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A process for preparing a porous collagen matrix from connective tissue, said process comprising treating connective tissue with a solution of hydrogen peroxide effective for preparing the porous collagen matrix.
2 . The process according to claim 1 , wherein the solution of hydrogen peroxide has a concentration between 0.1 and 10%.
3 . The process according to claim 1 , wherein the connective tissue is treated at a temperature ranging from 4 to 60.
4 . The process according to claim 1 , the process further comprising steps of freezing the connective tissue treated with a solution of hydrogen peroxide, wherein the step of freezing is carried out at a proper temperature with a proper temperature reduction rate, and lyophilizing the connective tissue effective for preparing the porous collagen matrix.
5 . A process for preparing a porous collagen matrix from connective tissue, said process comprising treating connective tissue with an acidic solution effective for preparing the porous collagen matrix.
6 . The process according to claim 5 , wherein the acidic solution is selected from a group consisting of peracetic acid, hydrochloric acid, oxalic acid, acetic acid and sulfuric acid.
7 . The process according to claim 5 , wherein the acidic solution has a concentration of 0.01 to 4M.
8 . The process according to claim 5 , wherein the acidic solution comprises at least a salt with a proper concentration.
9 . The process according to claim 8 , wherein the salt has a proper concentration of 0.01 to 4M of sodium chloride.
10 . The process according to claim 5 , the process further comprising steps of freezing the connective tissue treated with an acidic solution, wherein the step of freezing is carried out at a proper temperature with a proper temperature reduction rate, and lyophilizing the connective tissue effective for preparing the porous collagen matrix.
11 . A process for preparing a porous collagen matrix from connective tissue, the process comprising steps of treating connective tissue with an acidic solution followed by a solution of hydrogen peroxide, freezing said connective tissue at a proper temperature under a proper temperature reduction rate, and lyophilizing said connective tissue effective for preparing the porous collagen matrix.
12 . The process according to claim 11 , wherein the solution of hydrogen peroxide has a concentration between 0.1 and 10%.
13 . The process according to claim 11 , wherein the connective tissue is treated at a temperature ranging from 4 to 60.
14 . The process according to claim 11 , wherein the acidic solution is selected from a group consisting of peracetic acid, hydrochloric acid, oxalic acid, acetic acid and sulfuric acid.
15 . The process according to claim 11 , wherein the treatment with an acidic solution is divided into two steps, a first step comprising treating the connective tissue with an acetic acid solution of 0.1 to 6M and a second step comprising treating the connective tissue with an acetic acid solution of 0.01 to 2M.
16 . The process according to claim 15 , wherein the acetic acid solution of 0.01 to 2M comprises at least a salt.
17 . The process according to claim 16 , wherein the salt comprises sodium chloride of 0.01 to 4M.
18 . The process according to claim 11 , the process further comprising a step of treating the connective tissue with a solution containing SDS (sodium dodecyl sulphate).
19 . The process according to claim 18 , wherein the solution contains 0.01 to 10% of SDS.
20 . The process according to claim 19 , wherein the solution contains a chelating agent.
21 . The process according to claim 20 , wherein the chelating agent is EDTA (ethylene diamine tetra-acetic acid) with a concentration of 0.01 to 100 mM.
22 . A porous collagen matrix prepared by the process according to claim 1 .
23 . A porous collagen matrix prepared by the process according to claim 4 .
24 . A porous collagen matrix prepared by the process according to claim 5 .
25 . A porous collagen matrix prepared by the process according to claim 7 .
26 . A porous collagen matrix prepared by the process according to claim 9 .
27 . A porous collagen matrix prepared by the process according to claim 10 .
28 . A porous collagen matrix prepared by the process according to claim 11 .
29 . A porous collagen matrix prepared by the process according to claim 15 .
30 . A porous collagen matrix prepared by the process according to claim 17 .
31 . A porous collagen matrix prepared by the process according to claim 20 .
32 . A porous collagen matrix prepared by the process according to claim 22.Join the waitlist — get patent alerts
Track US2003036636A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.